Roth Capital Starts Nektar Therapeutics (NKTR) at Buy

May 24, 2012 9:22 AM EDT Send to a Friend
Get Alerts NKTR Hot Sheet
Price: $15.93 +6.34%

Rating Summary:
    7 Buy, 1 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 14 | New: 51
Trade NKTR Now!
Join SI Premium – FREE
Roth Capital initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy. PT $10.00.

For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.

Shares of Nektar Therapeutics closed at $6.97 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment